Although XPF polymorphisms are associated with an increased risk of NB (Zhuo et al., 2018) and the NER pathway is related to chemoresistance to cisplatin (Duan et al., 2020), there is no data in the literature associating XPB and NB. This evidence concerns the gene ERCC3 and neuroblastoma.